Ponesimod Shown Promising for MRI Outcomes in Relapsing MS
Compared to teriflunomide, ponesimod showed benefit for magnetic resonance imaging (MRI) outcomes in relapsing multiple sclerosis.
All articles by Neurology Advisor Contributing Writer
Extended-Release Amantadine Improves Walking Speed in Patients With MS
ADS-5102, the extended release capsule form of amantadine, may clinically benefit walking speed in patients with multiple sclerosis.
Amiloride, Fluoxetine, Riluzole Do Not Reduce Atrophy Rates in Secondary Progressive MS
In secondary progressive multiple sclerosis, amiloride, fluoxetine, and rizuole treatments do not translate into long-term reduction in atrophy rates.
CSF UCH-L1 Biomarker Predictive of Long-Term Disease Progression in MS
Baseline levels of ubiquitin C-terminal hydrolase L1 in cerebral spinal fluid may be predictive of long term multiple sclerosis progression.
Eculizumab Reduces Relapse Risk in Neuromyelitis Optica Spectrum Disorder
The terminal complement inhibitor eculizumab reduced the risk of relapse in patients with neuromyelitis optica spectrum disorder (NMOSD).
Ozanimod May Be a Safe Long-Term Treatment for Relapsing MS
Ozanimod may be a safe and well-tolerated treatment for relapsing forms of multiple sclerosis.
SSRIs May Improve Response to First-Line DMT in Relapsing-Remitting MS
Individuals with relapsing-remitting MS who respond suboptimally to DMT may experience improvement with the addition of an SSRI.
Hypertension Onset May Occur Earlier in MS Patients Born After 1965
Researchers analyzed whether hypertension onset occurs at an earlier age in individuals with multiple sclerosis who were born post-1965.
Wahls Elimination Diet Reduces Fatigue and Improves Quality of Life for MS Patients
The Wahls elimination diet had more significant effects on quality of life for individuals with relapsing-remitting multiple sclerosis as compared to the Swank diet.
DMTs Most Effective Among Certain Subgroups of Individuals With MS
Effectiveness of disease modifying therapies for multiple sclerosis was shown to be associated with shorter disease duration and lower relapse rate.
-
Loading...
-
Loading...
Next post in ACTRIMS Forum 2020
